Abdelkarim Hussam, Durie Matthew, Bellomo Rinaldo, Bergmeir Christoph, Badawi Omar, El-Khawas Khaled, Pilcher David
Department of Intensive Care, Austin Hospital, Heidelberg, VIC, Australia.
Intensive Care Unit, Melbourne Health, Parkville, VIC, Australia.
J Asthma. 2020 Apr;57(4):398-404. doi: 10.1080/02770903.2019.1571082. Epub 2019 Jan 31.
: To compare the characteristics, use of invasive ventilation and outcomes of patients admitted with critical asthma syndrome (CAS) to ICUs in Australia and New Zealand (ANZ), and a large cohort of ICUs in the United States (US). : We examined two large databases of ICU for patients admitted with CAS in 2014 and 2015. We obtained, analyzed, and compared information on demographic and physiological characteristics, use of invasive mechanical ventilation, and clinical outcome and derived predictive models. : Overall, 2202 and 762 patients were admitted with a primary diagnosis of CAS in the ANZ and US databases respectively (0.73% vs. 0.46% of all ICU admissions, < 0.001). A similar percentage of patients received invasive mechanical ventilation in the first 24 h (24.7% vs. 24.4%, = 0.87) but ANZ patients had lower respiratory rates and higher PaCO levels. Overall mortality was low (1.23 for ANZ and 1.71 for USA; = 0.36) and even among invasively ventilated patients (2.4% for ANZ vs. 1.1% for USA; = 0.38). However, ANZ patients also had longer length of stay in ICU (43 vs. 37 h, = 0.001) and hospital (105 vs. 78 h, = 0.003). : Patients admitted to ANZ and USA ICU with CAS are broadly similar and have a low and similar rate of invasive ventilation and mortality. However, ANZ patients made up a greater proportion of ICU patients and had longer ICU and hospital stays. These findings provide a modern invasive ventilation and mortality rates benchmark for future studies of CAS.
为比较澳大利亚和新西兰(澳新)重症监护病房(ICU)收治的重症哮喘综合征(CAS)患者与美国一大群ICU中此类患者的特征、有创通气使用情况及转归。我们查阅了2014年和2015年收治CAS患者的两个大型ICU数据库。我们获取、分析并比较了人口统计学和生理学特征、有创机械通气使用情况、临床转归等信息,并建立了预测模型。总体而言,澳新和美国数据库中分别有2202例和762例患者以CAS作为主要诊断入院(分别占所有ICU入院患者的0.73%和0.46%,P<0.001)。在最初24小时内接受有创机械通气的患者比例相似(24.7%对24.4%,P = 0.87),但澳新患者呼吸频率较低,动脉血二氧化碳分压(PaCO)水平较高。总体死亡率较低(澳新为1.23,美国为1.71;P = 0.36),即使在接受有创通气的患者中也是如此(澳新为2.4%,美国为1.1%;P = 0.38)。然而,澳新患者在ICU的住院时间更长(43小时对
37小时,P = 0.001),在医院的住院时间也更长(105小时对78小时,P = 0.003)。入住澳新和美国ICU的CAS患者大致相似,有创通气率和死亡率较低且相似。然而,澳新患者在ICU患者中占比更大,在ICU和医院的住院时间更长。这些发现为未来CAS研究提供了现代有创通气和死亡率基准。